Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-ti

EQS-News: ABIVAX / Key word(s): Capital IncreaseAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors 22.02.2023 / 18:05 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR DISTRIBUTION IN OR INTO THE...

Related Keywords

Australia ,Japan ,United States ,Paris ,France General ,France ,United Kingdom ,America ,French ,Hartmutj Ehrlich ,Asia Pacific ,Kepler Cheuvreux ,Company Board Of Directors ,Garnier Co ,Holding Incubatrice ,Deerfield Management Company ,Financial Services ,Distribution Services ,Great Point Partners ,Lifesci Capital ,Abivax The Company ,Company Board Of Directors On ,European Union Withdrawal ,Certain Of The Company ,Euronext ,None Of The Company ,Capital Increase ,Deep Track Capital ,Sofinnova Partners ,Venrock Healthcare Capital Partners ,Commodore Capital ,Samsara Biocapital ,Boxer Capital ,Euronext Paris ,Latin America ,North America ,New Shares ,Annual General Shareholder Meeting ,Chief Executive Officer ,Truffle Capital ,Modified Mayo Score ,Registration Document ,French Autorit ,Prospectus Regulation ,Bryan Garnier Securities ,Member States ,European Economic Area ,Member State ,French Monetary ,Financial Code ,Securities Act ,Markets Act ,European Union ,Financial Promotion ,Financial Promotion Order ,Relevant Persons ,European Economic ,United Kingdom For ,Corporate News ,Regulatory Announcements ,